β2 adrenergic receptor gene Arg16Gly polymorphism is associated with therapeutic efficacy of benazepril on essential hypertension in Chinese

Clinical and Experimental Hypertension

Volumn 26, Issue 6, 2004, Pages 581-592

  Huang, Guo ^a,b   Xing, Houxun ^b   Hao, Ke ^b,g   Peng, Shaojie ^b   Wu, Di ^b   Guang, Wenwei ^b   Huang, Aiqun ^b   Hong, Xiumei ^b   Wang, Yuanping ^b   Feng, Yan ^b   Zhang, Yan ^c,d   Li, Jianping ^b,d   Chen, Changzhong ^b   Wang, Binyan ^b   Zhang, Xuejun ^b   Li, Dong ^a   Yu, Yunxian ^a   Liu, Jing ^a   Zhu, Guoying ^c   Huo, Yong ^c   Chen, Dafang ^b,c   Hou, Yongtai ^e   Wang, Xiaobin ^f   Xu, Xin ^g   Niu, Tianhua ^h   Xu, Xiping ^a,b,g   more..

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ADRB2 gene; Benazepril; Blood pressure; Gene polymorphism; Pharmacogenetics

Indexed keywords

ARGININE; BENAZEPRIL; BETA 2 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; GLYCINE; ANTIHYPERTENSIVE AGENT; BENZAZEPINE DERIVATIVE;

ADRB2 GENE; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHINESE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ASIAN; ETHNOLOGY; GENETICS; GENOTYPE; MIDDLE AGED;

ADULT; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BENZAZEPINES; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2;

EID: 20844460284     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200031839     Document Type: Article

References (40)

1. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
2. Ueshima H, Zhang XH, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000; 14:765-769.
3. Materson BJ, Reda DJ, Cushman WC, Massie BM, Preis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328:914-921.
4. Weinshilboum R. Inheritance and drug response. N Engl J Med 2003; 348:529-537.
5. Evans WE, McLeod HL. Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 2003; 348:538-549.
6. Moser M, Abraham PA, Bennett WM, Brachfeld N, Goodman RP, McKenney JM, Hollifield JW, Kirkendall WM, Lasseter KC, Leon AS, et al. The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study. Clin Pharmacol Ther 1991; 49:322-329.
7. Whalen JJ. Definition of the effective dose of the converting-enzyme inhibitor benazepril. Am Heart J 1989; 117:728-734.
8. Balfour JA, Goa KL. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 1991; 42:511-539.
9. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A 1987; 84:46-50.
10. Kazanietz MG, Enero MA. Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol. J Pharmacol Exp Ther 1990; 252:758-764.
11. Ramsdale EH, Otis J, Kline PA, Gontovnick LS, Hargreave FE, O'Byrne PM. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol. Am Rev Respir Dis 1991; 143:998-1001.
12. Portillo MP, Del Barrio AS, Garcia-Calonge MA, Martinez JA. Desensitization effect of in vivo treatment with metaproterenol on beta1, beta2 and beta3-adrenergic responsiveness in rat adipocytes. Life Sci 1996; 58:405-414.
13. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339.
14. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419.
15. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13:25-33.
16. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F. Beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33:1425-1430.
17. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101:2877-2882.
18. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, Skrabal F, Caulfield M. Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension 1997; 30:773-776.
19. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, Cockcroft J, Hall IP. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000; 18:167-172.
20. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y. Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001; 37:286-292.
21. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19(suppl 1):S36-S42.
22. Li D, Xing H, Hao K, Peng S, Wu D, Guang W, Huang A, Wang Y, Zhang Y, Yu Y, Li J, Chen C, Wang B, Zhu G, Huo Y, Chen D, Ronnenberg A, Niu T, Xu X. Hypertensive patients from two rural Chinese counties respond differently to benazepril: the anhui hypertension health care study. Ann Epidemiol 2004; 14:123-128.
23. MacNab M, Mallows S. Safety profile of benazepril in essential hypertension. Clin Cardiol 1991; 14:IV33-IV37, discussion IV51-5.
24. Postma CT, Dennesen PJ, de Boo T, Thien T. First dose hypotension after captopril; can it be predicted? A study of 240 patients. J Hum Hypertens 1992; 6:205-209.
25. Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, Pavan E, Pessina AC. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 1993; 31:295-300.
26. Niu T, Chen C, Yang J, Wang B, Wang Z, Schork N, Fang Z, Xu X. Blood pressure and the T174M and M235 T polymorphisms of the angiotensinogen gene. Ann Epidemiol 1999; 9:245-253.
27. Buffone GJ, Darlington GJ. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem 1985; 31:164-165.
28. Niu T, Struk B, Lindpaintner K. Statistical considerations for genome-wide scans: design and application of a novel software package polymorphism. Hum Hered 2001; 52:102-109.
29. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000; 50:211-223.
30. Ranade K, Shue WH, Hung YJ, Hsuing CA, Chiang FT, Pesich R, Hebert J, Olivier M, Chen YD, Pratt R, Olshen R, Curb D, Botstein D, Risch N, Cox DR. The glycine allele of a glycine/arginine polymorphism in the beta2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am J Hypertens 2001; 14:1196-1200.
31. Taylor DR, Kennedy MA. Beta-adrenergic receptor polymorphisms and drug responses in asthma. Pharmacogenomics 2002; 3:173-184.
32. O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, Taylor PW, Parmer RJ. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2000; 2:16-22.
33. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension 1983; 5:86-99.
34. Dage RC, Hsieh CP, Spedding M. Vasodilation by medroxalol mediated by beta 2-adrenergic receptor stimulation. J Cardiovasc Pharmacol 1983; 5:143-150.
35. Chitbangonsyn SW, Mahboubi P, Walker D, Rana BK, Diggle KL, Timberlake DS, Parmer RJ, O'Connor DT. Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach. J Hum Hypertens 2003; 17:319-324.
36. Jablonskis LT, Rogers PF, Lungershausen YK, Howe PR. Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats. J Auton Nerv Syst 1992; 39:119-126.
37. Sloman G. Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group. Am J Cardiol 1992; 70:113C-118C.
38. Giannattasio C, Cattaneo BM, Omboni S, Seravalle G, Bolla G, Turolo L, Morganti A, Grassi G, Zanchetti A, Mancia G. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992; 10:373-378.
39. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52:506-516.
40. Wang Z, Chen C, Niu T, Wu D, Yang J, Wang B, Fang Z, Yandava CN, Drazen JM, Weiss ST, Xu X. Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001; 163:1404-1409.